Chiara Gai | Chair
EvoBiotech

Chiara Gai, Chair, EvoBiotech

Dr. Chiara Gai earned a PhD in Medical Pathophysiology from the Department of Medical Sciences of the University of Turin in 2017. Dr. Gai is working with Prof. Camussi since 2014 in the field of EV derived from stem cells. She set up several in vitro tests for the assessment of the minimal efficacious dose of EV, to measure EV biologic activity and their pro-angiogenic properties, their ability to promote cell proliferation, apoptosis, cell migration, oxidative stress and ROS production. She has also experience in molecular characterization of EV from different sources. Dr. Gai is co-founder and chair of EvoBiotech since February 2019.

Appearances:



Conference Day 2 - Wednesday 1st April 2020 @ 14:30

Innovative plant-based solution for chronic wound care

  • EvoBiotech discovered an innovative plant-derived active ingredient which promote regeneration of skin and blood vessel.
  • The active ingredient can be incorporated into an advanced dressing used for chronic wounds, improving its therapeutic efficacy.
  • This product can fill the urgent need for new medications that can cure ulcers faster and with an accessible price compared to products currently on the market.
last published: 04/Jun/20 08:25 GMT

back to speakers